Mast Cell / Immune

MCAS

Mast Cell Activation Syndrome — automated daily PubMed feed of peer-reviewed research.

— studies

An automated collection of peer-reviewed publications on MCAS (Mast Cell Activation Syndrome) and related mast cell activation phenotypes. MCAS involves inappropriate release of mast cell mediators (histamine, tryptase, prostaglandins, and others), causing multisystem symptoms such as flushing, urticaria, gastrointestinal distress, tachycardia, brain fog, and anaphylactoid reactions. It is increasingly studied in Long COVID, PACVS, POTS, and ME/CFS overlap syndromes, with growing interest in antihistamines, mast cell stabilizers, and dietary interventions.

Related resources: Therapeutic agents and trials for MCAS and overlapping conditions — Therapeutic Agents Tracker → · Biomarker Atlas →
⚠
Disclaimer: Automated PubMed feed. Not medical advice. Consult a qualified healthcare provider.
🔍
Source: PubMed / NCBI

Part of the Open Source Medicine Foundation Network

Open Source Medicine Foundation The OSMF hub — advancing open-source biomedical research infrastructure, tools, and evidence synthesis.
SpikeProtein.site Database and research resource on SARS-CoV-2 spike protein biology, persistence, and clinical implications.
Vaccine Data Navigator Open-access navigation tool for vaccine adverse event reporting and surveillance data.
PACVS Research Summit Annual summit convening researchers, clinicians, and patients on PACVS science.